Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Natera
MedTech
Natera offers Invitae $52.5M for prenatal screening tests
After earning a permanent injunction barring the use of some of Invitae’s genetic tests, Natera is taking another product suite off Invitae's hands.
Andrea Park
Jan 22, 2024 10:27am
The highest paid medtech CEOs
Dec 12, 2022 3:00am
Natera launches lung DNA test for catching transplant rejections
Oct 18, 2021 11:38am
Qiagen pays $40M to work with Natera on prenatal screening tests
Mar 14, 2018 7:50am
Imperial, University of Leicester tap Natera for breast cancer study
Nov 1, 2017 11:55am
Germany’s numares debuts urine test for kidney rejection
Apr 5, 2017 10:00am
